Tedicareby FastHSR

Physician

Guy J Pean, MD

According to 2025 Medicare claims, Guy Pean, MD (NPI: 1255442513) practices addiction medicine in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. This provider's primary affiliated billing organization is PALLADIA INC (NPI: 1710055827; TIN: 237089380) and primary practice location at 10035-2906.

Pean's data goes back to 2015 and runs through 2024. Part D data shows 147 prescription claims across 37 beneficiaries totaling $61,354 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $8,339 to $61,354. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$31K$61K2015 Drug cost: $8,339 (USD; Tot_Drug_Cst)2016 Drug cost: $6,612 (USD; Tot_Drug_Cst)2017 Drug cost: $9,269 (USD; Tot_Drug_Cst)2018 Drug cost: $30,148 (USD; Tot_Drug_Cst)2019 Drug cost: $26,022 (USD; Tot_Drug_Cst)2020 Drug cost: $13,856 (USD; Tot_Drug_Cst)2021 Drug cost: $12,705 (USD; Tot_Drug_Cst)2022 Drug cost: $13,846 (USD; Tot_Drug_Cst)2023 Drug cost: $20,240 (USD; Tot_Drug_Cst)2024 Drug cost: $61,354 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R65$8,339
20161360$6,612
201715100$9,269
201827131$30,148
20191771$26,022
20201563$13,856
20211549$12,705
20221557$13,846
202319122$20,240
202437147$61,354

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl29837$6,473
Quetiapine FumarateQuetiapine Fumarate16465$69

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Guy J. Pean, MD?

Tedicare shows public-source Medicare data for Guy J. Pean, MD (NPI 1255442513), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Guy J. Pean, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Guy J. Pean, MD?

Guy J. Pean, MD is linked to PALLADIA INC (billing NPI 1710055827) in the available physician profile data.

Does Guy J. Pean, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.